She discusses her research on assays for measuring drug concentrations and anti-drug antibodies, as well as algorithmic approaches to proactive therapeutic drug monitoring and how they help patients with...
Patients with pulmonary arterial hypertension may experience sleep disturbance and poor sleep quality. Lea Ann Matura, PhD, RN, answers our questions about the association between sleep and biomarkers among...
Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and...
In this video, Dr Horst, from Vanderbilt University Medical Center, discusses current treatment challenges in the management of inflammatory bowel disease (IBD), the importance of choosing the right...
In this podcast, Alexander Rothman, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident...
A study team recently examined the risk of ischemic strokes and transient ischemic attacks among patients who discontinued vitamin K antagonist therapy. We spoke with lead authors Carlos Martinez, MD, MSc,...
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH,...
Atul Deodhar, MD, MRCP, from Oregon Health and Science University, answers our questions about the findings from the DISCOVER-1 clinical trial on the efficacy of guselkumab for the treatment of patients...
He discusses his research on cenobamate as adjunctive therapy for adults with uncontrolled focal seizures, how the results of this research aided in cenobamate's approval by the Food and Drug...
